Healthcare provider profile · identity verified

Kelly Emch, MD

Family Practice · SYLVANIA, OH · NPI 1649272444

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	504	160
Atorvastatin Calcium	Atorvastatin Calcium	429	155
Lisinopril	Lisinopril	395	135
Rosuvastatin Calcium	Rosuvastatin Calcium	392	131
Metoprolol Succinate	Metoprolol Succinate	304	97
Pravastatin Sodium	Pravastatin Sodium	300	89
Amlodipine Besylate	Amlodipine Besylate	294	106
Metformin Hcl Er	Metformin Hcl	282	83
Losartan Potassium	Losartan Potassium	281	100
Omeprazole	Omeprazole	219	75
Simvastatin	Simvastatin	218	72
Gabapentin	Gabapentin	182	54
Pantoprazole Sodium	Pantoprazole Sodium	169	56
Hydrochlorothiazide	Hydrochlorothiazide	164	73
Montelukast Sodium	Montelukast Sodium	158	42
Spironolactone	Spironolactone	150	43
Escitalopram Oxalate	Escitalopram Oxalate	149	39
Fluticasone Propionate	Fluticasone Propionate	142	62
Sertraline Hcl	Sertraline Hcl	139	48
Carvedilol	Carvedilol	136	37
Alprazolam	Alprazolam	135	57
Potassium Chloride	Potassium Chloride	131	40
Ozempic	Semaglutide	121	29
Alendronate Sodium	Alendronate Sodium	119	39
Trazodone Hcl	Trazodone Hcl	115	35
Furosemide	Furosemide	108	33
Meloxicam	Meloxicam	108	36
Fluoxetine Hcl	Fluoxetine Hcl	100	32
Lorazepam	Lorazepam	97	32
Metformin Hcl	Metformin Hcl	88	39
Tramadol Hcl	Tramadol Hcl	84	19
Allopurinol	Allopurinol	82	28
Prednisone	Prednisone	82	71
Paroxetine Hcl	Paroxetine Hcl	81	24
Tamsulosin Hcl	Tamsulosin Hcl	79	25
Synthroid	Levothyroxine Sodium	78	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	74	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	20
Metoprolol Tartrate	Metoprolol Tartrate	74	32
Zolpidem Tartrate	Zolpidem Tartrate	72	20
Buspirone Hcl	Buspirone Hcl	66	21
Albuterol Sulfate Hfa	Albuterol Sulfate	63	34
Finasteride	Finasteride	60	17
Januvia	Sitagliptin Phosphate	60	18
Ibuprofen	Ibuprofen	54	23
Bupropion Xl	Bupropion Hcl	53	17
Citalopram Hbr	Citalopram Hydrobromide	53	13
Sodium Chloride	0.9 % Sodium Chloride	52	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	20
Venlafaxine Hcl Er	Venlafaxine Hcl	51	12
Tizanidine Hcl	Tizanidine Hcl	48	20
Eliquis	Apixaban	46	11
Clopidogrel	Clopidogrel Bisulfate	44	14
Donepezil Hcl	Donepezil Hcl	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Famotidine	Famotidine	40	20
Mirtazapine	Mirtazapine	40	suppressed
Glimepiride	Glimepiride	39	16
Hydralazine Hcl	Hydralazine Hcl	39	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Lovastatin	Lovastatin	38	12
Terazosin Hcl	Terazosin Hcl	38	11
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Meclizine Hcl	Meclizine Hcl	36	16
Clonazepam	Clonazepam	35	suppressed
Cephalexin	Cephalexin	34	31
Methylprednisolone	Methylprednisolone	33	30
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Azithromycin	Azithromycin	30	26
Klor-Con M20	Potassium Chloride	29	suppressed
Ondansetron Odt	Ondansetron	28	11
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Repaglinide	Repaglinide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Atenolol	Atenolol	24	12
Cilostazol	Cilostazol	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	15
Digoxin	Digoxin	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amoxicillin	Amoxicillin	21	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Estradiol	Estradiol	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	17
Doxycycline Hyclate	Doxycycline Hyclate	20	20
Glipizide	Glipizide	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	11
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nystatin	Nystatin	18	12
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Anastrozole	Anastrozole	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error